Join us for an evening dedicated to strengthening collaboration in medication management. Murrumbidgee Primary Health Network (MPHN) is partnering with local hospitals to deliver the ASPIRE Trial in our region, aimed at reducing medication-related harm during transitions of care.
We’ve also established a Medication Safety Hub, providing a dedicated Medication Safety Pharmacist to support you with queries related to the ASPIRE trial, Home Medicines Review (HMR) referrals, and other medication safety concerns. Speakers for the event include:
Dr Jason Bennie (PhD), Chief Data Officer and Research Lead - Murrumbidgee Primary Health Network
Mahmoud Mahmoud, District Chief Pharmacist – Murrumbidgee Local Health District
Melissa Catanzariti, Medication Safety Pharmacist Research Assistant (ASPIRE) – Murrumbidgee Primary Health Network
Dr Stephanie Armstrong, Senior Staff Specialist Geriatrician, Head of the Department of Geriatrics - Murrumbidgee Local Health District
Light dinner provided.
You do not need to be part of the trial to attend.
About the ASPIRE Trial:
The ASPIRE Trial (A systems approach to enhancing community-based medication review) is a national study focused on improving post-discharge medication review processes through a PHN-based model. Sponsored by the University of Sydney, the trial aims to reduce hospital readmissions by fostering better communication and coordination between hospitals, GPs, pharmacists, and patients, particularly during the high-risk transition from hospital to home.
